Download this page as PDF Contact: Stephen Seliger, Core Director
Core Resources — Clinical Phenotyping
ClinicalTrials.Gov Identifier NCT01873235
ADPKD Cohort: Longitudinal Cohort Study of adult ADPKD patients without ESRD and eGFR>15 ml/min/1.73m 2
Follow-up Duration: Up to 6 years
Biorepository:
- Urine
- Plasma
- Sera
- DNA
- N=298 participants enrolled
- Age: 45.1 (13.6) years
- 60% Female
- 13.4% African American
- 41.5% with eGFR<60 ml/min/1.73m 2
- Mayo Risk Class 1C, 1D, or 1E: 75.6%
Clinical Phenotyping Clinical history:
- Age of diagnosis and initial presenting symptoms (e.g., pain, hematuria)
- History of renal and cyst complications: pain, hemorrhage, infection, rupture, stones, hematuria, and nocturia.
- Cardiovascular complications – valvular heart disease, aortic aneurysms
- CNS complications – including presence and size of intra-cranial aneurysms
- Non-ADPKD co-morbid conditions and medications
- Tolvaptan Use
- Incident End – stage Kidney Disease (and type of renal replacement therapy)
Family History – Including age of ESRD of affected family members, and history of extra-renal complications including hepatic disease and intra-cranial aneurysms.
Physical Exam
- Resting blood pressure and heart rate
- Height, weight, body mass index
Clinical Laboratory Results
- Electrolytes (estimated GFR from CKD-Epi equation)
- Lipid profile
- Liver function panel
- Complete Blood Count
- Urine protein
Renal and Hepatic MRI:
- Total Kidney Volume (TKV)
Cardiovascular measures (on subset of participants):
- Aortic Pulse wave velocity
- Left Ventricular Mass
- Left Ventricular Ejection fraction
- Left Ventricular and atrial dimensions
- Valvular dysfunction
Cognitive Function (Montreal Cognitive Assessment (MoCA) and Depressive symptoms (Beck Depression Inventory).
- Montreal Cognitive Assessment (MoCA)
- Beck Depression Inventory-II
Health-related Quality of Life:
- NIH PROMIS instruments
Please note: There may be additional costs for the materials and shipping associated with your requests. You will be contacted directly by the provider regarding these costs.

